Clinical trials
Recruiting Pancreatic Neoplasms trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Revolution Medicines, Inc. | 2 |
| AbbVie | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Bayer | 1 |
| Bristol-Myers Squibb | 1 |
| City of Hope Medical Center | 1 |
| Cosomil, Inc. | 1 |
| Daiichi Sankyo | 1 |
| Incyte Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 17 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Esophageal Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Stomach Neoplasms | 4 |
| Uterine Cervical Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Endometrial Neoplasms | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Urinary Bladder Neoplasms | 3 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.